FDA Highlights Hands-On Approach To China Inspections In Budget Plan
This article was originally published in The Tan Sheet
Executive Summary
The budget request targets an increase in pharmaceutical programs’ budget authority to boost the number of FDA staff focused on China’s manufacturing. The proposed $10 million increase, including $5.6 million to be allocated toward manufacturing, provides for additional inspections, educational efforts and inspectors in China.